Janney Montgomery Scott
CADL icon

Janney Montgomery Scott’s Candel Therapeutics CADL Stock Holding History

Janney Montgomery Scott’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
30,472
+3,400
+13% +$18.5K ﹤0.01% 2670
2025
Q4 		$153K Sell
27,072
-3,314
-11% -$17.8K ﹤0.01% 2837
2025
Q3 		$155K Buy
30,386
+3,096
+11% +$17.9K ﹤0.01% 2771
2025
Q2 		$138K Buy
27,290
+6,200
+29% +$31.9K ﹤0.01% 2615
2025
Q1 		$119K Buy
21,090
+10,765
+104% +$88K ﹤0.01% 2597
2024
Q4 		$90K Sell
10,325
-1,340
-11% -$7.92K ﹤0.01% 2637
2024
Q3 		$81K Buy
11,665
+50
+0.4% +$311 ﹤0.01% 2593
2024
Q2 		$72K Buy
+11,615
New +$87.2K ﹤0.01% 2548

Other funds holding CADL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janney Montgomery Scott's CADL Position: Q1 2026 in Review

Janney Montgomery Scott increased its Candel Therapeutics (CADL) stake by 13% in Q1 2026, buying an estimated $18.5K and bringing the position to 30,472 shares worth $149K. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

Janney Montgomery Scott first reported a position in CADL in Q2 2024 and has held it in 8 quarters since. The position peaked at $155K in Q3 2025. 114 funds tracked by Wall St. Rank hold CADL as of Q1 2026.

  • Janney Montgomery Scott held 30,472 shares of Candel Therapeutics worth $149K as of Q1 2026.
  • Janney Montgomery Scott bought 3,400 Candel Therapeutics shares in Q1 2026, an estimated $18.5K.
  • Candel Therapeutics made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2670 holding.
  • Janney Montgomery Scott first reported a position in Candel Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Janney Montgomery Scott's Candel Therapeutics position peaked at $155K in Q3 2025.
  • 114 funds tracked by Wall St. Rank held Candel Therapeutics as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.